Reports
Reports
Sale
The global orthopaedic soft tissue repair market size was valued at USD 6.4 billion in 2023, driven by the prevalence of new technical advances to treat soft tissue injuries across the globe. The market is expected to grow at a CAGR of 6.3% during the forecast period of 2024-2032, with the values likely to reach USD 11.1 billion by 2032.
Orthopaedic soft tissue repair includes offering treatment for soft tissue injuries such as sprains, contusions, bursitis, strains, stress injuries and more. Such injuries often occur in sports injuries but can also happen due to recurring falls. The orthopaedic soft tissue repair may include inserting implants and grafting among others. The natural soft tissue healing process depends on the extent of injury, age, and overall health of a patient.
Musculoskeletal system injuries have often been treated with the help of several physical modulations like physiotherapies, surgical procedures, and pharmacological agents like non-steroidal anti-inflammatory drugs and corticosteroid viscosupplementation. Although these treatments have proved to be successful, investigators have been working on designing efficient, accurate and time saving treatment methods with minimal side effects.
The orthopaedic soft tissue repair market value has increased with the emergence of new devices and techniques. Sam x1 by ZetrOZ Systems is the latest innovation in soft tissue and injury healing. It is enabled with a unique wireless system that allows decreased pain, increased blood circulation and movement by allowing secure and discreet attachment for balancing weight effectively. ChitogenX Inc. has also been working on its ORTHO-R proprietary regenerative medicine platform. In June 2023, they partnered with Bruder Consulting & Venture Group (BCVG) to accelerate the development.
With the increasing adoption of 3D printing systems, the market is witnessing mergers and acquisitions to facilitate prompt and accurate treatment for patients. For instance, 3D Systems and Theradaptive have joined forces to promote bone and tissue growth using protein-based material binding treatments to coat 3D printed medical devices. This technique is set to improve healing and yield better outcomes. Zimmer Biomet Holdings Inc. acquired Embody Inc.’s entire collagen-based biointegrative solutions portfolio. Such partnerships will fuel the orthopaedic soft tissue repair market growth by bringing in innovative solutions in the forecast period.
Market Breakup by Product
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Out of the total musculoskeletal injuries reported in the United States, approximately 50% of it turn out to be soft tissue injuries. With growing incidence, the orthopaedic soft tissue repair market demand has increased in recent years. In addition, soft issue injuries get more common with ageing due to weakened connective tissues leading to wear and tear of soft tissues. Hence, the repair market is steadily growing.
The United States holds a major portion of orthopaedic soft tissue repair market share. This market is expected to remain almost similar even in the forecast period. Factors contributing to the market share include a robust infrastructure and constant mergers and acquisitions between companies yielding better opportunities for research and development. For instance, the US-based Carmell Corporation has announced a merger with Axolotl Biologix for crafting active soft tissue repair and aesthetics.
The Asia-pacific can be anticipated to witness a rapid growth in the forecast period, owing to the increased occurrence of government aided initiatives to improve the medical infrastructure. It is also a preferred destination for medical tourism which will bring substantial revenue to boost the market value.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Orthopaedic Soft Tissue Repair Market Overview
3.1 Global Orthopaedic Soft Tissue Repair Market Historical Value (2017-2023)
3.2 Global Orthopaedic Soft Tissue Repair Market Forecast Value (2024-2032)
4 Global Orthopaedic Soft Tissue Repair Market Landscape
4.1 Global Orthopaedic Soft Tissue Repair Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Orthopaedic Soft Tissue Repair Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
5 Global Orthopaedic Soft Tissue Repair Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Orthopaedic Soft Tissue Repair Market Segmentation
6.1 Global Orthopaedic Soft Tissue Repair Market by Product
6.1.1 Market Overview
6.1.2 Fixation Devices
6.1.3 Tissue Patch
6.1.4 Laparoscopic Instruments
6.2 Global Orthopaedic Soft Tissue Repair Market by Application
6.2.1 Market Overview
6.2.2 Anterior Cruciate Ligament
6.2.3 Rotator Cuff Repair
6.2.4 Vaginal Prolapse
6.2.5 Lateral Epicondylitis
6.2.6 Achilles
6.2.7 Gluteal Tendon
6.2.8 Biceps Tenodesis
6.2.9 Hip Arthroscopy
6.2.10 Cruciate Ligament Repair
6.2.11 Pelvic Organ Prolapse
6.3 Global Orthopaedic Soft Tissue Repair Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Orthopaedic Clinics
6.3.4 Ambulatory Centres
6.3.5 Others
6.4 Global Orthopaedic Soft Tissue Repair Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Orthopaedic Soft Tissue Repair Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Orthopaedic Soft Tissue Repair Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Orthopaedic Soft Tissue Repair Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Others
10 Latin America Orthopaedic Soft Tissue Repair Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Orthopaedic Soft Tissue Repair Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 South Africa
11.5 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Clinical Trials Analysis
13.1 Analysis by Trial Registration Year
13.2 Analysis by Trial Status
13.3 Analysis by Trial Phase
13.4 Analysis by Product
13.5 Analysis by Application
13.6 Analysis by Geography
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnerships and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Supplier Landscape
18.1 Stryker
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Company News
18.1.5 Certifications
18.2 Arthrex, Inc.
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Company News
18.2.5 Certifications
18.3 Zimmer Biomet
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Company News
18.3.5 Certifications
18.4 DePuy Synthes Companies
18.4.1 Financial Analysis
18.4.2 Financial Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Company News
18.4.5 Certifications
18.5 CONMED Corporation
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Company News
18.5.5 Certifications
18.6 Smith & Nephew
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Company News
18.6.5 Certifications
18.7 Bauerfeind
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Company News
18.7.5 Certifications
18.8 OTTOBOCK
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Company News
18.8.5 Certifications
18.9 Medi GmbH & Co. KG
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Company News
18.9.5 Certifications
18.10 BSN Medical
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Company News
18.10.5 Certifications
18.11 Thuasne USA
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Company News
18.11.5 Certifications
18.12 ADC Energy Systems LLC
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Company News
18.12.5 Certifications
18.13 Wright Medical Group N.V.
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Company News
18.13.5 Certifications
19 Global Orthopaedic Soft Tissue Repair Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 6.4 billion in 2023, driven by the increasing technical advances in the orthopaedic treatment market.
The market is anticipated to grow at a CAGR of 6.3% during the forecast period of 2024-2032, likely to reach a market value of USD 11.1 billion by 2032.
The increased demand is due to occurrence of more sports injuries and the prevalence of a geriatric population, which is more susceptible to tissue wear and tear.
The market is inclining towards advanced treatment techniques like the development of regenerative medicine platforms and wireless systems. Mergers and acquisitions between companies is also a market trend.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
It includes fixation devices, tissue patch, and laparoscopic instruments.
The product finds wide applications in anterior cruciate ligament, rotator cuff repair, vaginal prolapse, lateral epicondylitis, Achilles, gluteal tendon, biceps tenodesis, hip arthroscopy, cruciate ligament repair, and pelvic organ prolapse.
Major end users include hospitals, orthopaedic clinics, and ambulatory centres, among others.
Key players involved in the market are Stryker, Arthrex, Inc., Zimmer Biomet, DePuy Synthes Companies, CONMED Corporation, Smith & Nephew, Bauerfeind, OTTOBOCK, Medi GmbH & Co. KG, BSN Medical, Thuasne USA, ADC Energy Systems LLC, and Wright Medical Group N.V.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.